SCHEMBL14848256

SCHEMBL14848256

C/N=c1/c(F)cc(-c2cc(F)cc(F)c2)cn1C(=N)COc1ccnc2cc(OC)ccc12

nearest known ligand 0.46

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
MET P08581 20/20 0.46
CYP3A4 P08684 3/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18061173 0.89 MET (0.48) METCYP3A4
SCHEMBL9910347 0.71 MET (0.83) METCYP3A4
SCHEMBL18061169 0.69 MET (0.61) MET
SCHEMBL18885789 0.68 MET (0.45) METCYP3A4
SCHEMBL4900121 0.67 MET (0.54) METCYP3A4
SCHEMBL9910302 0.67 MET (0.84) METCYP3A4
SCHEMBL29878429 0.66 MET (0.54) METCYP3A4
SCHEMBL2700581 0.66 MET (0.54) METCYP3A4
SCHEMBL3839146 0.65 TLR8 (0.60) METCYP3A4
SCHEMBL8145365 0.64 HTR1A (0.61) MET

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2578583-A1 Fused heterocyclic derivatives and methods of use Amgen Inc. (US) 2013-04-10 EP disclosed